Pharmacodynamic study of F(ab')2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris.
about
Platelet CD62 expression and PDGFAB secretion in patients undergoing PTCA and treatment with abciximabEptifibatide: a potent inhibitor of the platelet receptor integrin glycoprotein IIb/IIIaTherapeutic Implications of a Specific Murine Monoclonal Antibody (7E3) to the Platelet Receptor GPIIb/IIIa.ABCIXIMAB: a new antiaggregant used in angioplasty.The evolving role of platelet glycoprotein IIb/IIIa inhibitors in the management of acute coronary syndromes.Prevention of thrombosis and rethrombosis and enhancement of the thrombolytic actions of recombinant tissue-type plasminogen activator in the canine heart by DMP728, a glycoprotein IIb/IIIa antagonistThe human platelet fibrinogen receptor: clinical and therapeutic significance.Overview of clinical trials with glycoprotein IIb-IIIa receptor antagonists in the prevention and management of coronary.Reduced red blood cell destruction by antibody fragmentsThe kinetics of integrilin limited by obesity: a multicenter randomized pharmacokinetic and pharmacodynamic clinical trial.Translational research: forging a new cultural identityBiography of Barry S. Coller.Monoclonal antibodies to platelet glycoprotein IIb/IIIa as antithrombotic agents.The arterial thrombotic process and emerging drugs for its control.Thrombin and antithrombotic therapy in interventional cardiology.Platelet thromboembolism.New antithrombotic strategies for resistant thrombotic processes.Cost-effectiveness analysis of abciximab: a Canadian hospital perspective.Overview Biologicals and Immunologicals: Integrin antagonists as modulators of adhesionApolipoprotein A-IV binds αIIbβ3 integrin and inhibits thrombosis
P2860
Q28185641-32A3D215-D732-42A9-B8AD-66378150EB36Q28193526-65C9A913-7C06-4E4A-9AF5-4215FBCE9943Q33392640-3A318696-8790-4C35-A705-FEDCF6E74041Q33497071-6F71FB5C-99BB-488D-AA8C-3A9AB504742DQ33689211-9A698EFD-F254-4777-85F6-64918604DA3EQ34793710-1B4937F0-4212-4F76-989D-59E12A42263CQ35898379-2F7DCA6B-6759-4B0E-9314-BF8A53FF70A7Q36179701-C286EDCB-52A5-4E10-A3B0-CC10E9108AACQ36701838-50425C03-B69B-488F-8E73-289F24BBE81AQ36727015-736E041A-9FB2-4D01-AD32-9A32D859C21FQ37215078-883901F2-6E32-4543-A155-417647D0898BQ37513170-22C363F8-C899-4F3D-89E1-58E848A7A014Q37711747-71BA188D-CD74-49DF-A17A-E88A039605CBQ40486473-F34E6B4E-5B71-4E48-BD91-DF3C48CD89B4Q40486965-934B57BD-B8D9-44F8-8CFC-F08E48F30CFBQ40662538-99C63B9C-F2CE-475C-8BD5-8CDE659BA488Q40727618-33DB3D92-CF91-45CB-AB02-7E3F5C48C521Q48027994-A3D5E92F-7FF5-4CCB-A8F1-BC4F8357A9C1Q58058255-949A07C9-1D15-43B3-9F58-ADA82D0B6AC2Q58762020-0B64D0C7-BE25-4598-B5A5-8038F3A245C2
P2860
Pharmacodynamic study of F(ab')2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris.
description
1990 nî lūn-bûn
@nan
1990 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Pharmacodynamic study of F
@nl
Pharmacodynamic study of F(ab' ...... with unstable angina pectoris.
@ast
Pharmacodynamic study of F(ab' ...... with unstable angina pectoris.
@en
type
label
Pharmacodynamic study of F
@nl
Pharmacodynamic study of F(ab' ...... with unstable angina pectoris.
@ast
Pharmacodynamic study of F(ab' ...... with unstable angina pectoris.
@en
prefLabel
Pharmacodynamic study of F
@nl
Pharmacodynamic study of F(ab' ...... with unstable angina pectoris.
@ast
Pharmacodynamic study of F(ab' ...... with unstable angina pectoris.
@en
P2093
P2860
P356
P1476
Pharmacodynamic study of F(ab' ...... with unstable angina pectoris.
@en
P2093
B S Coller
L W Gimple
R C Leinbach
P2860
P304
P356
10.1172/JCI114757
P407
P577
1990-08-01T00:00:00Z